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Background: Asthma genetics has been extensively studied and many genes have been associated with the
development or severity of this disease. In contrast, the genetic basis of allergic rhinitis (AR) has not been evaluated
as extensively. It is well known that asthma is closely related with AR since a large proportion of individuals with
asthma also present symptoms of AR, and patients with AR have a 5–6 fold increased risk of developing asthma.
Thus, the relevance of asthma candidate genes as predisposing factors for AR is worth investigating. The present
study was designed to investigate if SNPs in highly replicated asthma genes are associated with the occurrence
of AR.
Methods: A total of 192 SNPs from 21 asthma candidate genes reported to be associated with asthma in 6 or
more unrelated studies were genotyped in a Swedish population with 246 AR patients and 431 controls. Genotypes
for 429 SNPs from the same set of genes were also extracted from a Singapore Chinese genome-wide dataset
which consisted of 456 AR cases and 486 controls. All SNPs were subsequently analyzed for association with AR and
their influence on allergic sensitization to common allergens.
Results: A limited number of potential associations were observed and the overall pattern of P-values corresponds well
to the expectations in the absence of an effect. However, in the tests of allele effects in the Chinese population the
number of significant P-values exceeds the expectations. The strongest signals were found for SNPs in NPSR1 and
CTLA4. In these genes, a total of nine SNPs showed P-values <0.001 with corresponding Q-values <0.05. In the NPSR1
gene some P-values were lower than the Bonferroni correction level. Reanalysis after elimination of all patients with
asthmatic symptoms excluded asthma as a confounding factor in our results. Weaker indications were found for IL13
and GSTP1 with respect to sensitization to birch pollen in the Swedish population.
Conclusions: Genetic variation in the majority of the highly replicated asthma genes were not associated to AR in our
populations which suggest that asthma and AR could have less in common than previously anticipated. However,
NPSR1 and CTLA4 can be genetic links between AR and asthma and associations of polymorphisms in NPSR1 with AR
have not been reported previously.
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Allergic rhinitis (AR) is a major chronic respiratory disease
and the most common allergic disorder with a worldwide
prevalence of 10-25% [1]. It has long been recognized that
the development of AR is dependent on interactions be-
tween genetic and environmental factors and that the gen-
etic factors play a major role with an estimated heritability
for AR as high as 70-90% [2,3]. A large number of studies
have identified more than 100 single nucleotide polymor-
phisms (SNPs) associated with AR, but few of them have
been successfully replicated. The general reproducibility of
a majority of these AR associations was found to be low in
a previous study [4]. Only one genome-wide association
study (GWAS) has been performed to identify genetic var-
iants specifically for AR [5]. In that study, no associations
were detected at a genome-wide significance level, and
only two at a suggestive significance level. In addition, a
genome-wide meta-analysis based on self-reported AR
identified few genetic variants in spite of analyzing 2.2 mil-
lion SNPs in close to 4000 AR cases and 9000 controls [6].
Only one locus reached genome-wide significance and six
suggestive loci were identified. Comparing these two stud-
ies there were no significant association signals in com-
mon. In addition, no association signals of earlier linkage
and candidate gene association studies coincide with any
of the loci identified in the GWAS and the meta-study.
This is not surprising, since the replication of different
genotype-phenotype associations has in general proven to
be much more difficult than initially appreciated [7]. Ex-
perience gathered in several different diseases indicates
that there is a positive correlation between the ability to
replicate previous associations and the size and number of
previous studies. Thus, in diseases where many large pre-
vious association studies have been performed replication
is often more successful.
It is well known that asthma is closely related to AR
since a large proportion of individuals with asthma also
present symptoms of AR, and patients with AR have a 5–6
fold increased risk of developing asthma [8-10]. Asthma
genetics has been extensively studied and many genes have
been associated with the development or severity of this
disease. Ober and Hoffjan (2006) listed 118 genes that had
been reported to be associated with asthma or atopy-
related phenotypes [11]. Of these genes, 25 were positively
associated with asthma in six or more independent studies
and were thus highly implicated as true susceptibility genes
for asthma-related phenotypes. The original associations
were identified in many different types of studies; linkage,
positional cloning and candidate gene association studies
and were subsequently replicated mostly by association
studies. Several studies have investigated the reproducibil-
ity of asthma candidate gene associations. One study by
Rogers et al. (2009) investigated 160 associated SNPs from
39 genes from an Illumina 550k array in 422 families andsuccessfully replicated 10 SNPs in six genes [12]. At the
level of the gene they found additional support for associ-
ation in 15 of the 39 genes but none were significant after
adjustment for multiple comparisons. In a consortium-
based GWAS investigating 10,365 asthma patients with
16,110 controls a total of seven loci with genome-wide sig-
nificance were identified [13]. None of the implicated genes
overlapped with the genes identified in the study by Rogers
et al. [12]. A meta-analysis of GWAS in ethnically diverse
North American populations identified five susceptibility
loci, four of whom at previously reported loci [14]. Also
this study was very large and analyzed 5,416 patients with
replication in 12,649 patients. The combined results of the
many previous association studies for asthma illustrate the
challenges in the search and replication of risk factors
for asthma.
Due to the close relationship between the occurrence of
asthma and AR we hypothesize that these two phenotypes
have genetic risk factors in common. The present study
was thus designed to investigate if SNPs in highly repli-
cated asthma genes as reported in the Ober and Hoffjan
study [11] are associated with the occurrence of AR.
Methods
Subjects
The Swedish study population consists of 246 AR patients
(108 female, 138 male) and 431 control individuals (185 fe-
male, 246 male) and was recruited from southern Sweden
in 2003–2009. All subjects are unrelated and of western
European origin, with both parents born in Sweden. The
diagnosis of birch and/or grass pollen induced AR was
based on a positive history of AR for at least two years and
a positive skin prick test (SPT) or Phadiatop test with at
least class two to birch and/or timothy grass pollen. A total
of 59% of the patients showed a positive SPT for both aller-
gens. All patients were classified as having severe symptoms
i.e., nasal itching, sneezing, rhinorrhea and nasal congestion
during pollen season and they had all been treated with an-
tihistamines and nasal steroids during pollen seasons previ-
ous years. Control individuals had no history of AR or any
other atopic disease and had a negative SPT or Phadiatop
test. Genomic DNA was extracted from blood collected in
EDTA using QIAamp DNA Blood Maxi or Mini kits
(Qiagen, Hilden, Germany) and DNA concentrations deter-
mined by fluorometry using PicoGreen (Molecular Probes,
Invitrogen, Eugene, OR, USA). The Swedish study popula-
tion has previously been analyzed in several AR studies
[4,15-17]. The Singapore Chinese population consists of
448 AR patients (250 female, 198 male) and 462 control in-
dividuals (337 female and 125 male) and was collected in
Singapore between 2008 and 2010. The study population is
of Chinese origin, residence of Singapore and all subjects
are unrelated to one another. The diagnosis of dust mite in-
duced AR was based on interviews of medical history using
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panel of common allergens in Singapore including the
house dust mite Dermatophagoides pteronyssinus and
Blomia tropicalis. A total of 89% of the patients showed a
positive SPT for both allergens. AR is thus diagnosed
based on the presence of atopic status and typical AR
symptoms as defined by the ARIA 2008 guidelines i.e.,
two or more AR symptoms (nasal congestion, rhinorrhea,
nasal itching, sneezing) persisting for four or more days a
week during the past year. In this study, none of the pa-
tients suffered from severe asthma and less than 10% had
moderate asthma with continuous medication. Control in-
dividuals had no history of AR or any other atopic disease
and had a negative SPT. More detailed phenotypic charac-
teristics of the Singapore Chinese population have been
described previously [5]. Genomic DNA was extracted
from buccal cells obtained from a mouthwash of 0.9%
saline solution following a standardized protocol [18].
Samples were quantified in triplicate on the Nanodrop
(Thermo Fisher Scientific Inc, Wilmington, DE, USA). In
both populations, SPT were performed with saline buffer
as negative and histamine chloride as positive controls. A
wheal reaction diameter of more than three mm was con-
sidered a positive SPT response. SPT was only performed
if the AR cases had not taken any anti-allergic drugs for at
least three days prior to the test. Atopy is defined as a
positive SPT reaction to either one of allergens. The study
was approved by the Ethics Committee of the Medical
Faculty, Lund University and the Institutional Review
Board of National University of Singapore and written in-
formed consent was obtained from all subjects. This study
is also in compliance with the Helsinki declaration.Table 1 Minor allele frequencies (MAF) and P-values for Hard
P<0.05 in the Swedish population






IL10 rs3021094 1 206944952 0.092 0.16
NOD1 rs4363092 7 30503938 0.18 0.36
NOD1 rs4720003 7 30508992 0.18 0.37
NPSR1 rs2022142 7 34705950 0.10 1.0
NPSR1 rs1379925 7 34715128 0.091 1.0
NPSR1 rs1379923 7 34717238 0.25 0.41
NPSR1 rs17788770 7 34793991 0.10 0.68
NPSR1 rs17789834 7 34871328 0.19 0.32
SCGB1A1 rs11231085 11 62190448 0.36 0.74
CCL5 rs1065341 17 34198593 0.040 0.41
CCL5 rs3817655 17 34199641 0.17 0.12
CCL5 rs2107538 17 34207780 0.17 0.27
TBXA2R rs3786989 19 3604004 0.93 0.25
†Association with AR estimated using a χ2-homogeneity test with Q-values in paren
Odds ratio (OR) and 95% confidence interval were estimated by using the most comGenotyping
A total of 21 genes (IL4, IL13, CD14, MS4A2 (FCERB1),
IL4R (IL4RA), ADAM33, GSTM1, IL10, CTLA4, SPINK5,
LTC4S, NPSR1 (GPR154), NOD1 (CARD4), SCGB1A1
(CC16), GSTP1, STAT6, NOS1, CCL5, TBXA2R, ADRB2
and TGFB1) were selected from a compilation of 25 genes
reported to be associated with asthma phenotypes in six or
more unrelated independent studies [11]. SNPs of the 21
genes were analyzed for association with AR whereas no
SNPs were analyzed for HLA-DRB1, HLA-DQB1, TNF, and
LTA as they are located at the HLA locus. Since this study
investigates asthma genes for their eventual contribution
also to the AR phenotype, we use the gene as the replica-
tion unit and not the individual SNPs. For genotyping in
the Swedish study population, HapMap (release 24) data
were used to identify haplotype-tagging SNPs (r2 cut
off =0.8, and minor allele frequency cut off =0.2) for each
of the 21 genes. Non-synonymous SNPs reported in dbSNP
or HapMap with minor allele frequencies >5% was added
to this selection. Genotypes were determined using
the Sequenom MassARRAY MALDI-TOF system. Assay
design was made using the MassARRAY Assay Design ver.
2.0 software (Sequenom Inc, San Diego, CA, USA) and
primers were obtained from Metabion GmbH (Martinsried,
Germany). A total of 192 SNPs with a total genotyping rate
of 98.4% were analyzed for association with AR in 246 pa-
tients and 431 controls. Whole genome genotyping in the
Singapore Chinese population was performed using the
Illumina HumanHap 550 k BeadChip version 3 (Illumina,
San Diego, CA, USA) at the Genome Institute of Singapore
as described earlier [5]. Of the 21 genes initially selected,
three genes (LTC4S, NOD1 and GSTM1) had no SNPs iny-Weinberg (HW) and association tests for SNPs with
Association test† OR 95% CI
Allele Genotype Lower Upper
0.020 (0.72) 0.078 (0.92) 1.6 1.1 2.2
0.050 (0.72) 0.045 (0.92) 1.3 1.0 1.8
0.041 (0.72) 0.033 (0.92) 1.3 1.0 1.8
0.035 (0.72) 0.056 (0.92) 1.5 1.0 2.1
0.021 (0.72) 0.031 (0.92) 1.6 1.1 2.3
0.045 (0.72) 0.11 (0.92) 0.8 0.6 1.0
0.083 (0.72) 0.035 (0.92) 0.7 0.5 1.0
0.011 (0.70) 0.039 (0.92) 1.4 1.1 1.9
0.037 (0.72) 0.0049 (0.58) 1.3 1.0 1.6
0.027 (0.72) 0.085 (0.92) 1.8 1.1 3.2
0.0028 (0.29) 0.0088 (0.58) 1.6 1.2 2.1
0.0021 (0.29) 0.0069 (0.58) 1.6 1.2 2.1
0.038 (0.72) 0.086 (0.92) 0.6 0.4 1.0
thesis calculated according to Storey (2002).
mon allele as the referent and are reported for each minor allele.
Table 2 Association of SNPs with P<0.05 for sensitization
to allergens in the Swedish population




IL10 rs3024498 1 206941529 0.27 (0.95) 0.0094 (0.31)
IL10 rs3024492 1 206944112 0.17 (0.87) 0.025 (0.36)
IL13 rs20541 5 131995964 0.00040 (0.038) 0.58 (0.77)
IL13 rs848 5 131996500 0.00067 (0.043) 0.56 (0.77)
IL4 rs2243248 5 132008644 0.0044 (0.21) 0.52 (0.76)
IL4 rs2070874 5 132009710 0.051 (0.87) 0.016 (0.31)
IL4 rs2227284 5 132012725 0.015 (0.57) 0.18 (0.59)
IL4 rs2243266 5 132013789 0.046 (0.87) 0.014 (0.31)
IL4 rs2243288 5 132017944 0.046 (0.87) 0.013 (0.31)
SPINK5 rs4357026 5 147457939 0.77 (0.99) 0.048 (0.45)
SPINK5 rs9325073 5 147498652 0.90 (0.99) 0.020 (0.31)
SPINK5 rs1422993 5 147503820 0.96 (0.99) 0.015 (0.31)
SPINK5 rs4263489 5 147516195 0.049 (0.87) 0.61 (0.77)
LTC4S rs730012 5 179220638 0.042 (0.87) 0.57 (0.77)
NPSR1 rs323917 7 34741643 0.048 (0.87) 0.35 (0.63)
NPSR1 rs12534369 7 34804709 0.64 (0.96) 0.033 (0.43)
NPSR1 rs17170017 7 34874209 0.54 (0.95) 0.011 (0.31)
N.D. rs10897270 11 62183007 0.90 (0.99) 0.012 (0.31)
GSTP1 rs1138272 11 67353579 0.00022 (0.038) 0.20 (0.61)
NOS1 rs6490121 12 117708195 0.33 (0.95) 0.036 (0.44)
NOS1 rs12578547 12 117763347 0.091 (0.87) 0.018 (0.31)
NOS1 rs3782218 12 117771511 0.96 (0.99) 0.046 (0.45)
NOS1 rs17509231 12 117794323 0.43 (0.95) 0.011 (0.31)
IL4R rs1029489 16 27376217 0.46 (0.95) 0.039 (0.44)
Association between genotype and sensitization to allergens was analyzed
using a Kruskal-Wallis rank sum test. False discovery rate was quantified using
the q-value introduced by Storey(2002) and are given in parenthesis.
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SNP but was filtered out after quality control for SNPs. A
total of 413 SNPs from 17 unique genes with a total geno-
typing rate of 98.4% were analyzed for association with
AR in 448 patients and 462 controls. Additional samples
(921 AR patients, 390 controls) from the Singapore Chinese
cohort were genotyped for rs324981, using a Taqman-assay.
Reactions were carried out according to the manufacturer’s
protocol using an ABI PRISM 7900HT and the genotypes
determined using SDS 2.4 software (Applied Biosystems,
Foster City, CA, USA).
Statistical analysis
Statistical analyses were made using R statistical software
[19] and PLINK v1.07 [20]. Genotype frequencies were
calculated and tested for Hardy-Weinberg equilibrium in
both cases and controls. Allele and genotype frequencies
were then investigated for association with AR using a χ2-homogeneity test. Odds ratios and 95% confidence inter-
vals were estimated by using the most common allele as
the referent and are reported for each minor allele. Associ-
ations between SPT-response and genotype were analyzed
using Kruskal-Wallis rank sum test. False discovery rate
was quantified using the Q-value introduced by Storey
[21] and calculated using the software QVALUE (ver.1.0).
Results
Association with AR phenotype in the Swedish
population
A total of 192 SNPs from 21 genes were genotyped and an-
alyzed for association with AR in 246 patients and 431
controls. For each SNP two tests of association were made,
one of allele frequencies and one of genotype frequencies.
Table 1 shows the results of the association analysis for
SNPs with uncorrected P-values <0.05 and the correspond-
ing Q-values and ORs (for complete results see Additional
file 1: Table S1). In the tests of allele frequencies there were
two P-values <0.01 and 11 P-values <0.05. In the tests of
genotype frequencies there were three P-values <0.01
and eight P-values <0.05. None of the indicated SNPs had
Q-values <0.1. In the absence of any association, the
expected numbers of P-values <0.01 and <0.05 are 1.9 and
9.6, respectively, in each of the test categories. Thus, the re-
sults fit very well the expected pattern of P-values in the
absence of any effects.
Association with SPT response in the Swedish population
A Kruskal-Wallis rank sum test was used to investigate the
relationship between genotype and degree of sensitization
to birch and timothy grass in AR-patients. A total of 24
SNPs had P-values <0.05 in the tests of SPTs for birch or
timothy grass (Table 2 and Additional file 1: Table S1). In
the tests of birch there were three P-values <0.001, four at
P<0.01 and 10 at P<0.05 and in the test of timothy grass
there were one P-value <0.01 and 16 at P<0.05. The Q-
values of the three SNPs with P<0.001 for birch (rs1138272
in GSTP1, rs20541 and rs848 in IL13) were approximately
0.04 and all other Q-values were >0.1. The lowest P-value
(rs1138272) is below the level for a Bonferroni corrected
P-value of 0.05, i.e. 0.00022 vs. 0.00026. Although the over-
all distribution of P-values is close to the expectation
under the assumption of absence of any association, the
three P-values <0.001 can be considered an indication of
an effect that warrants further investigation.
Association with AR phenotype in the Chinese population
Of the 21 genes initially selected, a total of 413 SNPs from
17 genes were extracted from the Illumina Human Hap
550 k panel and tested for association with AR in the
Singapore Chinese population. Just as in the Swedish popu-
lation two association tests were made, one at the allele and
one at the genotype level. Table 3 shows the results of
Table 3 Minor allele frequencies (MAF) and P-values for Hardy-Weinberg (HW) and association tests for SNPs with
P<0.05 in the Chinese population






Association test OR 95% CI
Allele Genotype Lower Upper
CTLA4 rs231735 2 204402121 0.23 1.0 0.00090 (0.037) 0.0038 (0.12) 1.44 1.16 1.79
CTLA4 rs231804 2 204416891 0.22 0.93 0.00060 (0.028) 0.0025 (0.090) 1.46 1.18 1.82
CTLA4 rs1024161 2 204429997 0.34 0.57 0.0088 (0.21) 0.020 (0.34) 1.29 1.07 1.56
CTLA4 rs926169 2 204430997 0.34 0.89 0.0059 (0.20) 0.016 (0.29) 1.31 1.08 1.58
CTLA4 rs733618 2 204439189 0.40 1.0 0.012 (0.22) 0.030 (0.42) 0.79 0.66 0.95
CTLA4 rs231726 2 204449111 0.40 0.74 0.016 (0.22) 0.041 (0.50) 1.25 1.04 1.51
CTLA4 rs6748358 2 204465150 0.28 0.39 0.0077 (0.21) 0.0067 (0.18) 1.31 1.08 1.61
CTLA4 rs10197319 2 204471289 0.22 0.86 0.013 (0.22) 0.0058 (0.17) 1.31 1.06 1.63
CTLA4 rs3096851 2 204472127 0.40 0.90 0.015 (0.22) 0.028 (0.41) 1.26 1.05 1.51
CTLA4 rs3116504 2 204477299 0.40 0.90 0.015 (0.22) 0.028 (0.41) 1.26 1.05 1.51
SPINK5 rs7707803 5 147368427 0.33 0.23 0.021 (0.27) 0.077 (0.57) 1.25 1.03 1.52
SPINK5 rs7725292 5 147368581 0.33 0.28 0.017 (0.22) 0.061 (0.51) 1.27 1.04 1.54
SPINK5 rs10477360 5 147384474 0.50 0.90 0.037 (0.34) 0.066 (0.52) 0.82 0.69 0.99
SPINK5 rs12332673 5 147387572 0.12 0.17 0.045 (0.36) NA (NA) 0.75 0.56 0.99
SPINK5 rs11948836 5 147393693 0.12 0.17 0.039 (0.34) NA (NA) 0.74 0.56 0.99
SPINK5 rs17774892 5 147395161 0.12 0.88 0.035 (0.34) NA (NA) 0.74 0.55 0.98
SPINK5 rs10463396 5 147395535 0.20 1.0 0.016 (0.22) 0.053 (0.50) 0.76 0.60 0.95
SPINK5 rs17107650 5 147396591 0.12 0.17 0.039 (0.34) NA (NA) 0.74 0.56 0.99
SPINK5 rs1422982 5 147400217 0.20 1.00 0.016 (0.22) 0.053 (0.50) 0.76 0.60 0.95
SPINK5 rs17107673 5 147401681 0.12 0.29 0.041 (0.34) NA (NA) 0.74 0.56 0.99
SPINK5 rs4472254 5 147433830 0.20 0.69 0.016 (0.22) 0.044 (0.50) 0.76 0.60 0.95
SPINK5 rs7724165 5 147445445 0.50 0.80 0.027 (0.30) 0.054 (0.50) 1.23 1.02 1.47
SPINK5 rs4519913 5 147452004 0.50 0.85 0.024 (0.27) 0.057 (0.50) 0.81 0.68 0.97
ADRB2 rs11742519 5 148218501 0.45 0.90 0.039 (0.34) 0.056 (0.50) 1.21 1.01 1.45
NPSR1 rs411323 7 34668233 0.16 0.81 0.037 (0.34) 0.095 (0.62) 1.31 1.02 1.69
NPSR1/AAA1 rs10081183 7 34706738 0.45 0.66 0.0066 (0.21) 0.023 (0.36) 0.78 0.65 0.93
NPSR1/AAA1 rs1345267 7 34714584 0.46 0.31 0.012 (0.22) 0.036 (0.48) 0.79 0.66 0.95
NPSR1/AAA1 rs1419791 7 34722086 0.48 0.85 0.0096 (0.21) 0.010 (0.21) 1.27 1.06 1.52
NPSR1/AAA1 rs1419791 7 34722086 0.48 0.85 0.0096 (0.21) 0.010 (0.21) 1.27 1.06 1.52
NPSR1/AAA1 rs324374 7 34723121 0.48 0.90 0.0095 (0.21) 0.010 (0.21) 1.27 1.06 1.52
NPSR1/AAA1 rs324389 7 34744239 0.46 0.66 0.00010 (0.014) 0.00055 (0.044) 0.70 0.58 0.84
NPSR1/AAA1 rs10270663 7 34752923 0.46 0.52 0.000068 (0.014) 0.00038 (0.044) 0.69 0.58 0.83
NPSR1/AAA1 rs324396 7 34756648 0.42 1.0 0.00035 (0.021) 0.0012 (0.065) 1.40 1.16 1.68
NPSR1/AAA1 rs324957 7 34767897 0.43 0.61 0.00011 (0.014) 0.00052 (0.044) 1.44 1.20 1.73
NPSR1/AAA1 rs10267134 7 34769628 0.34 0.89 0.00039 (0.021) 0.0014 (0.065) 0.71 0.58 0.86
NPSR1/AAA1 rs10278663 7 34774996 0.34 0.83 0.00032 (0.021) 0.0012 (0.065) 0.70 0.58 0.85
NPSR1 rs324987 7 34787953 0.44 0.34 0.00021 (0.019) 0.00049 (0.044) 1.41 1.18 1.70
NPSR1 rs17199888 7 34830864 0.33 0.89 0.0022 (0.083) 0.0075 (0.18) 0.74 0.61 0.90
NPSR1 rs1419868 7 34834082 0.25 0.018 0.013 (0.22) 0.054 (0.50) 1.31 1.06 1.61
GSTP1 rs614080 11 67103863 0.28 0.44 0.40 (0.80) 0.050 (0.50) 1.09 0.89 1.33
NOS1 rs884847 12 116207996 0.15 0.90 0.26 (0.75) 0.043 (0.50) 1.01 0.90 1.50
NOS1 rs532967 12 116216722 0.20 0.55 0.032 (0.34) 0.0024 (0.090) 1.03 1.02 1.62
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Table 3 Minor allele frequencies (MAF) and P-values for Hardy-Weinberg (HW) and association tests for SNPs with
P<0.05 in the Chinese population (Continued)
NOS1 rs545654 12 116261432 0.32 0.47 0.019 (0.24) 0.043 (0.50) 1.19 0.65 0.96
NOS1 rs693534 12 116269101 0.28 0.64 0.0094 (0.21) 0.014 (0.29) 0.84 0.62 0.94
NOS1 rs3782221 12 116280264 0.49 0.31 0.024 (0.27) 0.047 (0.50) 1.08 0.67 0.97
NOS1 rs11068466 12 116320260 0.17 0.73 0.023 (0.27) 0.016 (0.29) 0.91 0.59 0.96
NOS1 rs10774914 12 116331323 0.12 0.56 0.042 (0.34) 0.10 (0.62) 1.13 1.01 1.78
IL4R rs3024535 16 27259622 0.16 0.023 0.034 (0.34) NA (NA) 1.31 1.02 1.68
IL4R rs3024585 16 27267345 0.38 0.12 0.034 (0.34) 0.088 (0.62) 0.82 0.68 0.99
IL4R rs2074570 16 27282658 0.07 0.63 0.040 (0.34) NA (NA) 1.45 1.02 2.07
†Association with AR estimated using a χ2-homogeneity test with Q-values in parenthesis calculated according to Storey (2002).
Odds ratio (OR) and 95% confidence interval were estimated by using the most common allele as the referent and are reported for each minor allele.
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values <0.05 and the corresponding Q-values and ORs (for
complete results see Additional file 2: Table S2). A total of
50 SNPs had P-values <0.05. In the association test of al-
leles there were nine P-values <0.001, 18 at P< 0.01 and a
total of 48 at P<0.05. All nine SNPs with P-values <0.001
had Q-values <0.05 and corresponds to rs10270663,
rs324389, rs324957, rs10278663, rs324396, rs10267134,
rs324987 in NPSR1/AAA1, and rs231804 and rs231735 in
CTLA4. In the tests of association at the genotype level, the
four lowest P-values were <0.001with Q-values <0.05 and
coincided with the lowest P-values in the allele test. In
addition, another nine P-values were <0.01 and five of them
had Q-values <0.1. Of these five, four also coincide with the
nine SNPs with P<0.001 in the allele test. In total, there
were 30 P-values <0.05. In the absence of any association,
the expected number of P-values <0.001, <0.01 and <0.05
are 0.4, 4.1 and 20.7, respectively, in each of the test cat-
egories. Thus, the observed numbers of significant P-values
exceeds the expectation in the absence of any association
for both the allele and the genotype tests. In the tests of al-
lele effects, three P-values were lower than 0.00012 which
is the Bonferroni limit at P=0.05 within each category. The
lowest P-value, 0.000068, is larger than 0.00003 equal to the
global Bonferroni limit for all tests taken together, but of
the same order of magnitude. Thus, these results give a
strong indication of a genetic effect of NPSR1/AAA1 and
CTLA4 on the occurrence of AR, i.e. these genes can be
considered strong candidates for future analyses.
In addition, we investigated the functional NPSR1 cod-
ing variant rs324981 (Ile107Asn), which is in complete
linkage disequilibrium with rs324987 (P-value for associ-
ation =0.00021, OR=1.41, see Table 3). A TaqMan assay
was used to determine the rs324981 genotypes of add-
itional individuals of the Singapore Chinese cohort (921
AR patients, 390 controls). The P-value of association
was 0.0070 with an odds ratio (OR) of 1.14 for the het-
erozygous genotype and an increased OR of 1.65 for the
homozygous genotype in comparison with the referencegenotype. Thus, both analyses support the involvement
of NPSR1 in AR.
Since genetic variation of all genes tested for association
with AR in the present study has previously been associ-
ated with asthma and since patients with AR have an in-
creased incidence of asthma, we investigated asthma as a
confounding factor for our results. Since the strongest as-
sociations are detected in the Chinese population, we ex-
cluded all Chinese patients with any asthmatic symptoms
and repeated the association analysis for this population
(Additional file 3: Table S3). Comparing the significant as-
sociation results before and after elimination of AR pa-
tients with asthma shows that: 1) The elimination of
144 patients with asthma out of 448 (32%) result in a gen-
eral increase in P-values corresponding to the loss of
power due to a smaller sample size, 2) the nine SNPs with
P-values <0.001 detected in the initial analysis of all 448
AR patients, all showed P-values ≤0.01 after elimination of
the 144 patients, 3) these SNPs also showed very small
changes in their ORs (<0.08), 4) most ORs were highly
similar before and after elimination of the 144 patients,
the exception being five SNPs in the NOS1 gene that may
indicate confounding due to asthma.Association with SPT response in the Chinese population
A Kruskal-Wallis rank sum test was used to investigate the
relationship between genotype and degree of sensitization
to D. pteronyssinus and B. tropicalis in AR-patients. All tests
of the SPT with an uncorrected P-value <0.05 are shown in
Table 4 (for complete results see Additional file 2: Table
S2). A total of 44 SNPs had P-values <0.05 in the tests
of D. pteronyssinus and B. tropicalis. In the tests of
B. tropicalis there were six P-values <0.01 and a total of
24 P-values <0.05. In the tests of D. pteronyssinus one P-
value was <0.001, six were <0.01 and a total of 22
were <0.05. None of the indicated SNPs had correspond-
ing Q-values <0.1. Thus, the tests of the SPT response
conformed well to the expectations under independence
Table 4 Association of SNPs with P<0.05 for sensitization to allergens in the Chinese population
Gene SNP ID Chromosome position Kruskal-Wallis test
B.tropicalis D. pteronyssinus
SPINK5 rs10477360 5 147384474 0.027 (0.65) 0.69 (1.0)
ADRB2 rs2163752 5 148125331 0.027 (0.65) 0.054 (0.92)
ADRB2 rs30306 5 148132557 0.028 (0.65) 0.074 (0.97)
ADRB2 rs30325 5 148143517 0.27 (0.82) 0.010 (0.52)
ADRB2 rs30328 5 148146640 0.28 (0.82) 0.025 (0.75)
ADRB2 rs30330 5 148148525 0.32 (0.82) 0.027 (0.75)
ADRB2 rs9285673 5 148153121 0.049 (0.78) 0.90 (1.0)
ADRB2 rs10075995 5 148273622 0.53 (0.82) 0.014 (0.52)
NPSR1/AAA1 rs2058163 7 34301616 0.049 (0.78) 0.025 (0.75)
NPSR1/AAA1 rs1419842 7 34321625 0.41 (0.82) 0.031 (0.75)
NPSR1/AAA1 rs2392268 7 34380952 0.44 (0.82) 0.031 (0.75)
NPSR1/AAA1 rs6947789 7 34417405 0.018 (0.65) 0.83 (1.0)
NPSR1/AAA1 rs736295 7 34417742 0.054 (0.79) 0.039 (0.75)
NPSR1 rs2530545 7 34663665 0.94 (0.90) 0.040 (0.75)
NPSR1 rs11761197 7 34666914 0.78 (0.90) 0.013 (0.52)
NPSR1 rs1379928 7 34667814 0.51 (0.82) 0.0098 (0.52)
NPSR1 rs2609224 7 34672931 0.62 (0.85) 0.011 (0.52)
NPSR1 rs2609220 7 34676579 0.68 (0.86) 0.0067 (0.52)
NPSR1 rs2531841 7 34686074 0.81 (0.90) 0.012 (0.52)
NPSR1 rs1419837 7 34692064 0.88 (0.90) 0.018 (0.62)
NPSR1 rs1419779 7 34779833 0.21 (0.82) 0.0011 (0.15)
NPSR1 rs324978 7 34780857 0.20 (0.82) 0.00098 (0.15)
NPSR1 rs1859409 7 34906409 0.049 (0.78) 0.83 (1.0)
NPSR1 rs4723388 7 34909345 0.0056 (0.51) 0.52 (0.98)
NPSR1 rs1186717 7 34937434 0.33 (0.82) 0.036 (0.75)
NPSR1 rs1637673 7 34964375 0.15 (0.82) 0.0081 (0.52)
NPSR1 rs4236340 7 34976719 0.0061 (0.51) 0.46 (0.98)
NPSR1 rs328902 7 34987368 0.41 (0.82) 0.038 (0.75)
NPSR1 rs328906 7 34990440 0.0080 (0.51) 0.58 (0.98)
NPSR1 rs2023328 7 34998155 0.0053 (0.51) 0.60 (0.98)
NPSR1 rs329240 7 35024965 0.41 (0.82) 0.038 (0.75)
MS4A2 rs540170 11 59636614 0.049 (0.78) 0.98 (1.0)
MS4A2 rs581133 11 59638882 0.043 (0.78) 0.99 (1.0)
NOS1 rs1093325 12 116179703 0.031 (0.7) 0.23 (0.98)
NOS1 rs1004356 12 116261755 0.026 (0.65) 0.43 (0.98)
IL4R rs3024585 16 27267345 0.0036 (0.51) 0.98 (1.0)
IL4R rs1805011 16 27281373 0.011 (0.51) 0.076 (0.97)
IL4R rs1805012 16 27281465 0.011 (0.51) 0.076 (0.97)
IL4R rs1805015 16 27281681 0.022 (0.65) 0.11 (0.97)
IL4R rs3024685 16 27284411 0.045 (0.78) 0.21 (0.98)
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Table 4 Association of SNPs with P<0.05 for sensitization to allergens in the Chinese population (Continued)
IL4R rs4787956 16 27285750 0.0087 (0.51) 0.17 (0.97)
IL4R rs4787426 16 27292232 0.026 (0.65) 0.37 (0.98)
ADAM33 rs512625 20 3596378 0.017 (0.65) 0.22 (0.98)
ADAM33 rs2853210 20 3606211 0.046 (0.78) 0.0010 (0.15)
Association between genotype and sensitization to allergens was analyzed using a Kruskal-Wallis rank sum test. False discovery rate was quantified using the
q-value introduced by Storey(2002) and are given in parenthesis.
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sensitization of the tested allergens.
Discussion
In this study, we investigated the SNP associations of well-
replicated asthma candidate genes with AR in two inde-
pendent populations, one Swedish and one Singapore
Chinese population. Since there are inherent differences in
the genetic architecture between the two populations and
this study investigates asthma genes for their eventual con-
tribution also to the AR phenotype, the gene was used as
the level of replication and not the individual SNP [22]. A
limited number of potential associations were observed
and the overall pattern of P-values corresponds in general
well to the expectations in the absence of an effect. How-
ever, in the tests of allele effects in the Chinese population,
the number of significant P-values exceeds the expecta-
tions. The strongest signals were found for SNPs in CTLA4
and NPSR1. In each of these genes, more than one SNP
showed P-values <0.05 with corresponding Q-values <0.05.
In the NPSR1 gene some P-values were lower than the
Bonferroni correction level indicating the existence of a
true association. When comparing the results from the two
populations, i.e. Table 1 vs Table 3 and Table 2 vs Table 4,
it is with few exceptions different genes that show signifi-
cant SNPs. This is what is expected if the significances
mainly are due to chance effects generated by the multiple
testing. The conclusion that there are few genes in com-
mon between AR and asthma is further strengthened by
this observation. On the other hand, there is one exception
to this, the NPSR1 gene that recurs in all four tables. This
observation in turn further point to this gene as the stron-
gest candidate for being a link between AR and asthma,
even if one keep in mind the fact that the NPSR1 gene is
represented by the largest number of SNPs in both popula-
tions. To further investigate this hypothesis, one SNP in
NPSR1 (rs324981) was evaluated in an independent sample
of 921 AR patients and 390 controls from the Singapore
Chinese population. The results (OR=1.65, P=0.007) fur-
ther strengthen this hypothesis.
Previous studies have reported significant associations for
a large region of 47 kb in the NPSR1 gene with asthma
even after Bonferroni correction for multiple comparisons
(P<0.001). Vergara et al. [23], investigated SNPs in the
NPSR1 (GPR154) gene and found associations with asthmaand total IgE. Furthermore, this gene has been replicated in
studies of Caucasian [24-28] and Chinese populations [29],
but was not replicated in a Mexican cohort of childhood
asthmatics [30]. Thus, the association between variation in
NPSR1 and asthma appear to be strongly supported. Since
the present study strongly indicates an association with
genetic variation in the NPSR1 gene also in AR, there is an
obvious risk of asthma being a cxonfounding factor for our
results. This was investigated by comparing the association
results before and after elimination of patients with any
symptoms of asthma. The results convincingly showed that
asthma is no confounding factor for the SNPs in NPSR1
and CTLA4 in the Chinese population.
The present result indicates that NPSR1 could be a gen-
etic link between AR and asthma and associations of
NPSR1 polymorphisms with AR have not been reported
prior to this.
Conclusion
In summary, we have identified NPSR1 and CTLA4 as po-
tential susceptibility genes for AR. However, these genes
need to be replicated in additional populations and further
characterized to elucidate their role in AR predisposition
and pathogenesis. The majority of the highly replicated
asthma genes were not associated with AR in our popula-
tions, which suggest that asthma and AR could be less
similar at the genetic level than previously anticipated.Additional files
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